MedX Health Corp., a medical device and software company, develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. More Details
+ 1 more risk
Limited growth with imperfect balance sheet.
Share Price & News
How has MedX Health's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: MDX is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 14% a week.
Volatility Over Time: MDX's weekly volatility (14%) has been stable over the past year.
7 Day Return
CA Medical Equipment
1 Year Return
CA Medical Equipment
Return vs Industry: MDX underperformed the Canadian Medical Equipment industry which returned 26.9% over the past year.
Return vs Market: MDX underperformed the Canadian Market which returned 36.3% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is MedX Health's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 year ago | Simply Wall StDoes MedX Health's (CVE:MDX) Share Price Gain of 38% Match Its Business Performance?
1 year ago | Simply Wall StThose Who Purchased MedX Health (CVE:MDX) Shares Three Years Ago Have A 59% Loss To Show For It
2 years ago | Simply Wall StIs MedX Health Corp's (CVE:MDX) CEO Pay Fair?
Is MedX Health undervalued compared to its fair value and its price relative to the market?
In this section, we usually try to help investors determine whether MedX Health is trading at an attractive price based on the cash flow it is expected to produce in the future. But as MedX Health has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.
This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.
How is MedX Health forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Forecasted annual revenue growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if MDX's forecast earnings growth is above the savings rate (1.5%).
Earnings vs Market: Insufficient data to determine if MDX's earnings are forecast to grow faster than the Canadian market
High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: MDX's revenue (94.5% per year) is forecast to grow faster than the Canadian market (6.5% per year).
High Growth Revenue: MDX's revenue (94.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if MDX's Return on Equity is forecast to be high in 3 years time
How has MedX Health performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: MDX is currently unprofitable.
Growing Profit Margin: MDX is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: MDX is unprofitable, and losses have increased over the past 5 years at a rate of 27.7% per year.
Accelerating Growth: Unable to compare MDX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MDX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (21.2%).
Return on Equity
High ROE: MDX's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.
How is MedX Health's financial position?
Financial Position Analysis
Short Term Liabilities: MDX has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: MDX has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: MDX has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: MDX's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MDX has sufficient cash runway for 0 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: MDX is forecast to have sufficient cash runway for 0 months based on free cash flow estimates, but has since raised additional capital.
What is MedX Health current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate MDX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate MDX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if MDX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if MDX's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of MDX's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Rob von der Porten
Mr. Robert von der Porten, also known as Rob, MBA, BA, has been Chairman of the Board of MedX Health Corp. from September 18, 2018 and serves as its Director since November 29, 2013. Mr. von der Porten ser...
CEO Compensation Analysis
Compensation vs Market: Insufficient data to establish whether Rob's total compensation is reasonable compared to companies of similar size in the Canadian market.
Compensation vs Earnings: Rob's compensation has increased whilst the company is unprofitable.
Experienced Management: MDX's management team is considered experienced (4.4 years average tenure).
Experienced Board: MDX's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.8%.
MedX Health Corp's company bio, employee growth, exchange listings and data sources
- Name: MedX Health Corp
- Ticker: MDX
- Exchange: TSXV
- Founded: 1999
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: CA$26.394m
- Shares outstanding: 175.96m
- Website: https://www.medxhealth.com
- MedX Health Corp
- 1495 Bonhill Road
- Unit #1
- L5T 1M2
MedX Health Corp., a medical device and software company, develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United S...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/05/12 23:07|
|End of Day Share Price||2021/05/12 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.